Are Elderly Patients With Clinically Localized Prostate Cancer Overtreated? Exploring Heterogeneity in Survival Effects

BACKGROUND: Clinical trial evidence shows minimal survival gains and higher complication rates from radical prostatectomy (RP) versus watchful waiting (WW) for elderly men with localized prostate cancer (PCa). It is believed that these patients are overtreated. The current analyses aim to explore patient-level heterogeneity in survival effects, examine matching of patients to treatments in practice, and identify patient characteristics driving heterogenous effects, in order to present more comprehensive evidence about the concerns of overtreatment. METHODS: Eleven-year all-cause and PCa-specific survival among SEER-Medicare patients diagnosed during 1996-2002 were analyzed using local instrumental variable approaches. RESULTS: A total of 8462 (77%) of 11,036 patients received RP. The average effects of RP over WW on 11-year overall and cancer-specific survival were 1.1 months (95%CI, -25, 28; P=0.94) and 1.7 months (95%CI, -25, 29; P=0.90) respectively; effects did not differ significantly according to age, race, grade, and stage. Fewer than 1% of patients had significant cancer-specific survival benefit from RP at the 10% level; 6% were expected to gain over 15 months from RP. However, patients with larger expected survival gains from RP were much more likely to receive RP in practice. Such positive self-selection was driven by PCa-specific survival than overall survival. Several comorbidities may play a critical role in predicting who could benefit from RP. CONCLUSIONS: Our analyses corroborate concerns about PCa overtreatment. A small fraction of screen-detected PCa patients derive survival benefits from RP. Prediction tools should account for patient comorbidities to accurately predict survival benefits of RP over WW

Cancer · Overall survival · Proportional hazards model · Prostate cancer · Prostatectomy · Stage (stratigraphy) · Watchful waiting · Cancer survivorship and care · Internal Medicine · Medicine · Oncology · Prostate Cancer Diagnosis and Treatment · Prostate Cancer Treatment and Research · Surgery

• Structural Equations, Treatment Effects, and Econometric Policy Evaluation1

  Open Access•James J Heckman, Edward Vytlacil•Econometrica•2005

  Incluir item

• Local instrumental variables and latent variable models for identifying and bounding treatment effects

  Open Access•James J Heckman, Edward Vytlacil et al.•Proceedings of the National…•1999

  Incluir item

• Studying Radiation Therapy Using Seer-Medicare-Linked Data

  Beth A Virnig, Joan L Warren et al.•Medical Care•2002

  Incluir item

• Use of Seer-Medicare Data for Measuring Cancer Surgery

  Gregory S Cooper, Beth A Virnig et al.•Medical Care•2002

  Incluir item